Allergan Successfully Invalidates Claims Relating to Using Botox to Treat Back Pain

by Jones Day

Allergan is typically the patent holder in these types of disputes, however, it recently successfully played the role of petitioner in an IPR against 1474791 Ontario Ltd.’s U.S. Patent No. 6,806,251 covering the use of botulinum toxin to treat spinal compression.  Ontario had asserted the ’251 patent against Allergan in litigation, accusing Allergan of infringing the patent through its purported off-label use of Botox® for treating back pain.   (N.D. Ill. 1:15-cv-03372)  The court stayed the case pending the result of the IPR.  (Id.)  In Allergan, Inc. and Allergan Sales, LLC v. 1474791 Ontario, Ltd., IPR2016-00102 (March 28, 2017), the PTAB found that Allergan had successfully invalidated all the challenged claims of the ’251 patent as obvious.

Claim 1 of the ‘251 patent recites:

A method of treating a disorder associated with spinal compression comprising administering an effective dose of botulinum toxin directly and solely to the intrinsic muscles of a patient in need of such therapy.

Claims 1-4, 6, and 7 were held obvious over Travell, a prior art reference that generally disclosed myofascial pain syndromes referred from myofascial trigger points and treatment methods for releasing the trigger points using botulinum toxin such as botulinum toxin A (“BTA”).

The Board found that a preponderance of evidence supported Petitioner’s position that trigger points as described in Travell were a “disorder associated with spinal compression.”  In reaching its conclusion, the Board credited the testimony of Petitioner’s expert, who testified that Travell disclosed association of treating trigger points with treatment of nerve compression, radiculopathy, and other disorders, all of which are associated with spinal compression.

The PTAB construed the terms “directly” and “solely” to mean that botulinum toxin is delivered precisely to the intrinsic muscles.  While the patent owner argued that Travell did not expressly teach BT injection “directly” or “solely” into intrinsic muscles, the Board found that the combined teachings in Travell taught and/or suggested BT injection into trigger points, taught that those trigger points were located within the intrinsic muscle, and taught in detail how to locate those trigger points in particular intrinsic muscles.  The Board further found that trigger points cause myofascial pain and can be associated with disorders associated with spinal compression, and that injecting botulinum toxin into a trigger point can effectively treat myofascial pain.

Claim 5 requires injecting between 1 and 30 mouse units of botulinum toxin.  It was held invalid over Travell in view of Cheshire, which disclosed injecting specific amounts of botulinum injection of trigger points using “a total dose of mouse units of botulinum toxin in 4ml normal saline divided equally among 2 or 3 sites.”

Ontario further contended that Travell taught away from the claimed invention.  While Travell discussed the challenges in locating trigger points, the Board noted that Travell did not “criticize, discredit, or otherwise discourage” practicing the disclosed method.  Even though there was a need for care and skill in making these trigger point injections, a person of ordinary skill in the art would have had a reasonable expectation of success in injecting botulinum toxin into trigger points in the intrinsic muscles.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Jones Day | Attorney Advertising

Written by:

Jones Day

Jones Day on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.